Johnson Investment Counsel Inc Tg Therapeutics, Inc. Transaction History

Johnson Investment Counsel Inc

  • $10.1 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023
SELL
$8.36 - $26.5 $384 - $1,219
-46 Reduced 0.26%
17,862 $149,000
Q2 2023

Aug 10, 2023
BUY
$15.48 - $35.0 $712 - $1,610
46 Added 0.26%
17,908 $444,000
Q2 2022

Aug 15, 2022
BUY
$3.74 - $10.66 $66,803 - $190,408
17,862 New
17,862 $76,000

Others Institutions Holding TGTX

# of Institutions
349
Shares Held
89.5M
Call Options Held
2.35M
Put Options Held
1.7M
View Full List

About TG THERAPEUTICS, INC.

TGTX Quotes by TradingView
  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $4.61B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Johnson Investment Counsel Inc Portfolio

Follow Johnson Investment Counsel Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Johnson Investment Counsel Inc, based on Form 13F filings with the SEC.

News

Stay updated on Johnson Investment Counsel Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email